Clinical Trial Update: Allogenic Adipose Tissue-derived Mesenchymal Stromal Cells for the Treatment of Primary Progressive Multiple Sclerosis [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial investigating allogeneic adipose tissue–derived mesenchymal stromal cells for primary progressive multiple sclerosis is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Progressive Multiple Sclerosis

Drugs mentioned

• Allogeneic adipose tissue-derived mesenchymal stromal cells (mesenchymal stromal cells)

Snippet

Sponsor: Rennes University Hospital | Conditions: Multiple Sclerosis | Phase 1 | Status: RECRUITING